Supporting patient empowerment and improving glycemic outcomes with connected pens and artificial intelligence. From DBLG1 to DBL4Pen

DIABELOOP SA |
Wednesday

Chair: Erik Huneker (FRA)

10:00 – 10:05IntroductionErik Huneker (FRA)
10:05 – 10:15How CGMs & connected pens are improving patient careLutz Heinemann (GER)
10:15 – 10:25“DBL-4pen” first simulator results & our clinical validation programPierre-Yves Benhamou (FRA)
10:25 – 10:30Q&AAll faculty